These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
678 related items for PubMed ID: 9626121
41. Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey. Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F. J Steroid Biochem Mol Biol; 2002 Jun; 81(2):159-64. PubMed ID: 12137806 [Abstract] [Full Text] [Related]
42. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin. Kraemer GR, Kraemer RR, Ogden BW, Kilpatrick RE, Gimpel TL, Castracane VD. Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436 [Abstract] [Full Text] [Related]
46. Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. Gebre-Medhin G, Husebye ES, Mallmin H, Helström L, Berne C, Karlsson FA, Kämpe O. Clin Endocrinol (Oxf); 2000 Jun; 52(6):775-80. PubMed ID: 10848883 [Abstract] [Full Text] [Related]
47. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, Casarosa E, Palumbo M, Genazzani AD, Luisi M. Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649 [Abstract] [Full Text] [Related]
48. Mechanisms of androgen deficiency in human immunodeficiency virus-infected women with the wasting syndrome. Grinspoon S, Corcoran C, Stanley T, Rabe J, Wilkie S. J Clin Endocrinol Metab; 2001 Sep; 86(9):4120-6. PubMed ID: 11549636 [Abstract] [Full Text] [Related]
49. Hirsutism: diagnostic approach and stimulation-suppression dynamics of androgens in the female. Biberoglu K, Behrman SJ. Int J Fertil; 1982 Sep; 27(3):146-52. PubMed ID: 6128319 [Abstract] [Full Text] [Related]
50. Prolactin has a direct effect on adrenal androgen secretion. Higuchi K, Nawata H, Maki T, Higashizima M, Kato K, Ibayashi H. J Clin Endocrinol Metab; 1984 Oct; 59(4):714-8. PubMed ID: 6090494 [Abstract] [Full Text] [Related]
51. The impact of peri-operative dexamethasone administration on the normal hypothalamic pituitary adrenal response to major surgical procedures. El-Sibai K, Rajpal A, Al-Aridi R, Selman WR, Arafah BM. Endocrine; 2017 Oct; 58(1):134-142. PubMed ID: 28865040 [Abstract] [Full Text] [Related]
52. The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulfate and androstenedione, but lowers serum cortisol, in insulin-resistant obese and hypertensive men. Beer NA, Jakubowicz DJ, Beer RM, Nestler JE. J Clin Endocrinol Metab; 1993 Jun; 76(6):1464-9. PubMed ID: 8501151 [Abstract] [Full Text] [Related]
53. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion. Lanzone A, Fulghesu AM, Guido M, Fortini A, Caruso A, Mancuso S. Fertil Steril; 1992 Aug; 58(2):296-301. PubMed ID: 1321739 [Abstract] [Full Text] [Related]
54. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels. Pang S, Wang M, Jeffries S, Riddick L, Clark A, Estrada E. J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633 [Abstract] [Full Text] [Related]
55. Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation. Rege J, Nakamura Y, Satoh F, Morimoto R, Kennedy MR, Layman LC, Honma S, Sasano H, Rainey WE. J Clin Endocrinol Metab; 2013 Mar; 98(3):1182-8. PubMed ID: 23386646 [Abstract] [Full Text] [Related]
56. Suppression of circulating delta 4-androstenedione and dehydroepiandrosterone sulfate during oral glucose tolerance test in normal females. Hubert GD, Schriock ED, Givens JR, Buster JE. J Clin Endocrinol Metab; 1991 Oct; 73(4):781-4. PubMed ID: 1832424 [Abstract] [Full Text] [Related]
57. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. Cleare AJ, O'Keane V, Miell JP. Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921 [Abstract] [Full Text] [Related]
58. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen JS. J Clin Endocrinol Metab; 2009 Jun; 94(6):1973-8. PubMed ID: 19318449 [Abstract] [Full Text] [Related]
59. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. Azziz R, Black VY, Knochenhauer ES, Hines GA, Boots LR. J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576 [Abstract] [Full Text] [Related]
60. Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol suppression in normal women. Meno-Tetang GM, Blum RA, Schwartz KE, Jusko WJ. J Clin Pharmacol; 2001 Nov; 41(11):1195-205. PubMed ID: 11697752 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]